Edition:
United States

Voyager Therapeutics Inc (VYGR.OQ)

VYGR.OQ on NASDAQ Stock Exchange Global Select Market

18.22USD
4:00pm EDT
Change (% chg)

$0.01 (+0.05%)
Prev Close
$18.21
Open
$18.36
Day's High
$18.59
Day's Low
$18.06
Volume
81,277
Avg. Vol
149,844
52-wk High
$31.91
52-wk Low
$11.54

Chart for

About

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company. The Company focuses on developing treatments for patients suffering from severe diseases of the central nervous system (CNS). The Company's pipeline consists of programs for CNS indications, including advanced Parkinson's disease; a monogenic form of amyotrophi... (more)

Overall

Beta: --
Market Cap(Mil.): $590.66
Shares Outstanding(Mil.): 32.44
Dividend: --
Yield (%): --

Financials

  VYGR.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -2.72 -- --
ROI: -48.56 1.50 12.72
ROE: -86.13 0.19 14.85

BRIEF-Voyager Therapeutics Rpeorts Q1 GAAP Loss Per Share Of $0.63

* VOYAGER THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS

May 10 2018

Earnings vs. Estimates